Literature DB >> 7174654

Phosphoenol-3-bromopyruvate. A mechanism-based inhibitor of phosphoenolpyruvate carboxylase from maize.

M H O'Leary, E Diaz.   

Abstract

Phosphoenol-3-bromopyruvate is an excellent competitive inhibitor (versus phosphoenolpyruvate) of maize phosphoenolpyruvate carboxylase (Ki = 30 microM), provided that preincubation of enzyme with inhibitor is avoided. If the enzyme is preincubated with inhibitor in the presence of Mn2+ and HCO3(-), complete inactivation occurs over the course of about 1 h. The inactivation is first order in enzyme and is saturable with respect to inhibitor, with an apparent Michaelis constant of 67.5 microM and a half-life at high inhibitor concentration of 13.4 min. The inactivation is inhibited by phospholactate and is much slower at low HCO3(-) concentration. Incubation of the enzyme with phosphoenol-3-bromopyruvate in the presence of H14CO3(-) and Mn2+ followed by treatment with NaBH4 leads to incorporation of 14C into the inactive enzyme. If treatment with NaBH4 is omitted, the enzyme is inactivated, but no 14C is incorporated into the inactive product. It appears that phosphoenol-3-bromopyruvate is a mechanism-based inactivator of phosphoenolpyruvate carboxylase, probably because of enzyme-catalyzed conversion to 3-bromooxalacetate, which alkylates the enzyme.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Interaction of acetyl phosphate and carbamyl phosphate with plant phosphoenolpyruvate carboxylase.

Authors:  D H Gonzalez; A A Iglesias; C S Andreo
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

2.  Inhibition of maize leaf phosphoenolpyruvate carboxylase by diethyl oxaloacetate.

Authors:  G H Walker; G E Edwards
Journal:  Photosynth Res       Date:  1990-08       Impact factor: 3.573

3.  Genomic analysis of Chthonomonas calidirosea, the first sequenced isolate of the phylum Armatimonadetes.

Authors:  Kevin C-Y Lee; Xochitl C Morgan; Peter F Dunfield; Ivica Tamas; Ian R McDonald; Matthew B Stott
Journal:  ISME J       Date:  2014-01-30       Impact factor: 10.302

Review 4.  The metabolic advantage of tumor cells.

Authors:  Maurice Israël; Laurent Schwartz
Journal:  Mol Cancer       Date:  2011-06-07       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.